Caspases and cytokines: Roles in inflammation and autoimmunity

Advances in Immunology

Volumn 73, Issue 73, 1999, Pages 265-299

  Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; DIABETOGENESIS; ENTERITIS; ENZYME ACTIVITY; ENZYME ANALYSIS; GRAFT VERSUS HOST REACTION; HASHIMOTO DISEASE; HEPATITIS; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ANIMALS; AUTOIMMUNITY; CASPASES; CYTOKINES; HUMANS; INFLAMMATION;

EID: 0033063179     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2776(08)60788-9     Document Type: Article

References (198)

1. Abbas, A. K. (1996). Die and let live: Eliminating dangerous lymphocytes. Cell 84, 655-657.
2. Akita, K., Ohtsuki, T., Nukada, Y., Tanimoto, T., Namba, M., Okura, T., Takakura-Yamamoto, R., Torigoe, K., Gu, Y., Su, M. S. S., Fujii, M., Satoh-Itoh, M., Yamamoto, K., Kohno, K., Ikeda, M., and Kurimoto, M. (1997). Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.l cells. J. Biol. Cliem. 272, 26595-26603.
3. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., and Lynch, D. H. (1993). Fas transduces activation signais in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235.
4. Alexander, H., Doherty, G., Burcsh, C., Venzon, D., and Norton, J. (1991). A recombinant human receptor anatagonist for interleukin-1 improves survival after lethal endotoxemia in mice J. Exp. Med. 173, 1029-1032.
5. Alnemri, E. S. (1997). Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases. J. Cell Biocliem. 64, 33-42.
6. Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996). Suppression of TNF-α-induced apoptosis by NF-κB, Science 274, 787-789.
7. Arend, W. (1993). Interleukin-1 receptor antagonist, Adv. Immunol. 54, 167-227.
8. + T cells from HIV-infected patients increases with disease progression. J. Mol. Med. 73, 591-593.
9. Arscott, P. L., and Baker, J. R. (1998). Apoptosis and thyroiditis. Clin. Immunol. Immunopathol. 87, 207.-217.
10. Badley, A. D., McElhinny, J. A., Leibson, P. J., Lynch, D. H., Alderson, M. R., and Paya, C. V. (1996). Upregulation of Fas ligand expression by human immunodeficiency virus in human macrohpages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70, 199-206.
11. + lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185, 55-64.
12. Baker, M., Rilet, R., Podack, L., and Levy, R. (1997). Graft versus host-disease-associated lymphoid hypoplasia and B-cell disfunction is dependent upon donor T-cell-mediated Fas-ligand function, but not perform function. Proc. Natl. Acad. Sci. U.S.A. 94, 1366-1371.
13. Bazzoni, F., and Beutler, B. (1996). The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334, 1717-1725.
14. Beg, A. A., and Baltimore, D. (1996). An essential role for NF-κB in preventing TNF-αinduced cell death. Science 274, 782-784
15. Beidler, D. R., Tewari, M., Friesen, P. D., Poirier, G., and Dixit, V. M. (1995). The baculovirus p35 protein inhibits Fas and tumor necrosis factor-induced apoptosis. J. biol. Chem. 270, 1-3.
16. Benoist, C., and Mathis, D. (1997). Cell death mediators in autoimmune diabetes - No shortage of suspects. Cell 89, 1-3.
17. Bergeron, L., Perez, G. I., Macdonald, G., Shi, L., Sun, Y., Jurisicova, A., Varmuza, S., Latham, K. E., Flaws, J. A., Salter, J. C. M., Hara, H., Moskowitz, M. A., Li, E., Greenberg, A., Tilly, J. L., and Yuan, J. (1998). Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12, 1304-1314.
18. Beutler, B., and Cerami, A. (1989). The biology of cachectin/TNF - A primary mediator of the host response Annu. Rev. Immunol. 7, 625-655.
19. Bobe, P., Bonardelle, D., Reynes, M., Godeau, F., Mahiou, J., Joulin, V., and Kiger, N. (1997). Fas mediated liver damage in mrl hemopoietic chimeras undergoing Ipr-mediated graft-versus-host disease. J. Immunol. 159, 4197-4204.
20. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APOl contains a sequence motif related to the death domain. J. biol. Chem. 270, 7795-7798.
21. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85, 803-815.
22. + T lymphocytes during HIV infection. J. Immunol. 156, 2282-2293.
23. Braun, M. Y., Lowin, B., French, L, Acha-Orbea, H., andTschopp, J. (1996). Gytotoxic T-cells deficient in both functional fas ligand and perforion show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183, 657-661.
24. Bromine, H., and Holt, J. (1996). Apoptosis in the heart: When and why? Mol. Cell. Biochem. 163-164, 261-275.
25. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., and Green, D. R. (1995). Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates, activation-induced apoptosis in T-cell hybridomas. Nature (London) 373, 441-444.
26. Burns, K., Martinon, F., Esslinger, C., Palil, H., Schneider, P., Bodmer, J.-L., Di Marco, F., French, L., and Tschopp, J. (1998). MyD88, an adapter protein involved in interleukin 1 signaling. The J. Biol. Chem. 273, 12203-12209.
27. Cahill, M. A., Peter, M. E., Kischkel, F. C., Chinnaiyan, A. M., Dixit, V. M., Krammer, P. H., and Nordheim, A. (1996). CD95 (APO I/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 13, 2087-2096.
28. Campbell, I. L., Kay, T. W., Oxbrow, L., and Harrison, L. C. (1991). Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/ Wehi mice. J. Clin. Invest. 87, 739-742.
29. Campion, G. V., Lebsack, M. E., Lookabaugh, J., Gordon, G., and Catalano, M. (1996). Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-IRa Arthritis Study Group. Arthritis BJwtim. 39, 1092-1101.
30. Center, D., Kornfeld, H., and Cruikshank, W. (1996). Interleukin 16 and its function as a CD4 ligand. Immunol. Today 17, 476-481.
31. Chen, R. H., and Chang, T. Y. (1997). Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis. Cell Growth Diff. 8, 821-827.
32. Chen, Y., Smith, M. R., Thirumalai, K., andZychlinsky, A. (1996). A bacterial invasin induces macrophage apoptosis by binding directly to ice. Embo J. 15, 3853-3860
33. Chen, J., Nagayama, T., Jin, K., Stetler, R., Zhu, R., Graham, S., and Simon, R. (1998). Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia.J. Neurosci. 18, 4914-4928.
34. Cheng, W., Li, B., Kajstura, J., Li, P., Wolin, M. S., Sonnenblick, E. H., Hintze, T. H., Olivetti, G., and Anversa, P. (1995). Stretch-induced programmed myocyte cell death. J. Clin. Incest. 96, 2247-2259.
35. Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, J. C. A., and Matis, L. A. (1997). The role of Fas in autoimmune diabetes. Cell 89, 17-24.
36. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. (1995). FADD, a novel death domain-containing protein, interacts with the death, domain of Fas and initiates apoptosis. Cell 81, 505-512.
37. Chinnaiyan, A. M., O'Rourke, K., Yu, G.-L., Lyons, R. H., Garg, M., Duan,' R., Xing, L., Gentz, R., Ni, J., and Dixit, V. M. (1996). Signal transduction by DR3, a death domaincontaining receptor related to TNFR-1 and CD95. Science 274, 990-992.
38. Chinnaiyan, A. M., Woffendin, C., Dixit, V. M., and Nabel, G. J. (1997). The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication, Nature Med. 3, 333-337.
39. Dbaibo, G. S., Perry, D. K., Garnard, C. J., Platt, R., Poirier, G. G., Obeid, L. M., and Hannun, Y. A. (1997). Gytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-a: CrmA and Bcl-2 target distinct components in the apoptotic pathwayJ. Exp. Med. 185, 481-490.
40. Debatin, K.-M., Fahrig-Faissner, A., Enenkel-Stoodt, S., Kreuz, W., Benner, A., and Krammer, P. II. (1994). High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children, Blood 3, 3101-3103.
41. De Maria, R., and Testi, R. (1998). Fas-FasL interactions: A common pathogenetic mechanism in organ specific autoimmunity. Immunol. Today 19, 122-126.
42. Dey, B., Yang, Y.-G., Szot, G., Pearson, D., and Sykes, M. (1998). Interleukin-12 inhibits graft-versus-host disease through a fas-mediated mechanism associated with alterations in donor T-cell activation and expansion. Blood 91, 3315-3322.
43. Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., and Krammer, P. II. (1995). Autocrine T-cell suicide mediated by APO-1 /(Fas/CD95). Nature (London) 373, 438-441.
44. Dinarello, C. (1994). The interleukin-1 family: 10-years of discovery FASEBJ. 8,1314-1325.
45. Dinarello, C., and Wolff, S. (1993). The role of interleukin-1 in disease. N. Engl J. Med. 328, 106-113.
46. Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S., and Husar, W. (1996). Involvement of the CD95 (APO-I/Fas) receptor/ligand system in multiple sclerosis brain.J. Exp. Med. 184, 1513-1518.
47. Drevlow, B., Capezio, J., Lovis, R., Jacobs, C., Landay, A., and Pope, R. (1993). Phase I study of recombinant human interleukin-1 receptor administered intra-articularly in active rheumatoid arthritis. Arthritis Rheum. 36, S39.
48. Drevlow, B. E., Lovis, R., Haag, M. A., Sinacore, J. M., Jacobs, C., Blosche, C., Landay, A., Moreland, L. W., and Pope, R. M. (1996). Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Elicum. 39, 257-265.
49. D'Souza, S., Bonetti, B., Balasingam, V., Cashman, N., Barker, P., Troutt, A., Raine, C., and Antel, J. (1996). Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184, 2361-2370.
50. Duan, II., and DLxit, V. M. (1997). RAIDD is a new; "death" adaptor molecule. Nature (London) 385, 86-89.
51. Elford, P. R., Heng, R., Revesz, L., and MacKenzie, A. R. (1995). Reduction of inflammation and pyrexia in the rat by oral administration of S DZ-224-015, an inhibitor of the interleukin1 beta converting enzyme. Br. J. Pharmacol. 115, 601-606.
52. Endres, M., Namura, S., Shimizu-Sasamata, M., Waeber, C., Zhang, L., Gomez-Isla, T., Hyman, B., and Moskowitz, M. (1998). Attentuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase Family. J. Cercb. Blood Flow Metab. 18, 238-247.
53. + T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists. Blood 87, 4959-4966.
54. Fanslow, W., Sims, J., Sassenfield, H., Morrissey, P., Gillis, S., Dower, S., and Widmer, M. (1990). Regulation of alloreactivity in cico by a soluble form of the interleukin 1 receptor. Science 248, 739-742.
55. Fantuzzi, G., Puren, A. J., Harding, M. W., Livingston, D. J., and Dinarello, C. A. (1998). Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-lbeta-converting enzyme (caspase-l)-deficient mice. Blood 91,2118-2125.
56. Finkel, T. IL, and Banda, N. K. (1994). Indirect mechanisms of HIV pathogenesis: How does HIV kill T cells? Ctirr. Opin. Immun 6, 605-615.
57. Finkel, T. IL, Tudor-Williams, G., Banda, N. K., Cotton, M. F., Curiel, T., Monks, C., Baba, T. W., Ruprecht, R. M., and Kupfer, A. (1995). Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1, 129-134.
58. Fisher, G. II., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., and Puck, J. M. (1995). Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
59. Fladmark, K. E., Gjertsen, B. T., Doskeland, S. O., and Vintermyr, O. K. (1997). Fas/ APO-1(CD95)-induced apoptosis of primary- hepatocytes is inhibited by cAMP. Biochem. Biophys. Res. Commun. 232, 20-25.
60. Fletcber, D. S., Agarwal, L., Chapman, K. T., Chin, J., Egger, L. A., Limjuco, G., Luell, S., MacIntyre, D. E., Peterson, E. P., and Thornberry, N. A. (1995). A synthetic inhibitor of interleuking-1 beta converting enzyme prevents endotoxin-induced interleukin-1 beta production in citro and in vivo. J. Interferon Cytokine Res. 15, 243-248.
61. French, L., and Tschopp, J. (1997). Thyroiditis and hepatitis: Fas on the road to disease. Nature Med. 3, 387-388.
62. Friedlander, H. M., Gagliardini, V., Hara, IL, Fink, K. B., Li, W., MacDonald, G., Fishman, M. C., Greenberg, A. IL, Moskowitz, M. A., and Yuan, J. (1997). Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal,and ischémie brain injury. J. Exp. Med. 185, 933-40.
63. Galle, P. R., Hofmann, W. J., Walczak, IL, Schaller, IL, Otto, G., Stremmel, W., Krammer, P. II., and Runkel, L. (1995). Involvement of the CD95 (APPO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
64. Games, S., Anel, A., Pineiro, A., and Naval, J. (1998). Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramid signalling pathway. Cell Death Diff. 5, 241-249.
65. Genestier, L., Prigent, A.-F., Paillot, R., Quemeneur, L., Durand, I., Banchereau, J., Revillard, J., and Bonnefoy-Berard, N. (1998). Caspase-dependent ceramide production in Fas-and H LA class I-mediated peripheral T cell apoptosis.J. biol. Cliem. 273,5060-5066.
66. Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., Wong, W., Kamen, R., Tracey, D., and Alien, H. (1997). Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature (London) 386, 619-622.
67. Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R., and Galluzzo, A. (1997). Potential involvement of Fas and its ligand in the pathogenesis of Hashimpto's thyroiditis. Science 275, 960-963.
68. Glynn, J. M., McElligott, D. L., and Mosier, D. E. (1996). Apoptosis-induced by HIV infection in 119 T cells is blocked by ICE-family protease, inhibition but not by a Fas (CD95) antagonist. J. Immunol. 157, 2754-2758.
69. Golstein, P. (1997). Controlling cell death. Science 275, 1081-1082.
70. Gougeon, M. L., and Montagnier, L. (1993). Apoptosis in AIDS. Science 260,' 1269-1270.
71. Gougeon, M. L., Garcia, S., Heeney, J., Tschopp, R., Lecoeur, II., Guetard, D., Raine, V., Dauguet, C., and Montagnier, L. (1993). Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Rctmciniscs 9, 553-563.
72. Gougeon, M.-L., Lecoeur, IL, Dulioust, A., Enouf, M.-G., Crouvoisier, M., Goujard, C., Debord, T., and Montagnier, L. (1996). Programmed cell death in peripheral lymphocytes from HlV-infected persons.J. Immunol 156, 3509-3520.
73. Gu, Y., Kuida, K., Tsutsui, IL, Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, IL, Nakanishi, K., Kurimoto, M., Tanimoto, T., Flavell, R. A., Sato, V., Harding, M. W., Livingston, D. J., and Su, M. S.-S. (1997). Activation of interferon-γ inducing factor mediated by interleukin-1/3 converting enzyme. Science 275, 206-209.
74. Hannun, Y. A. (1996). Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859.
75. Hara, IL, Fink, K., Endres, M., Friedlander, R. M., Gagliardini, V., Yuan, J., and Moskowitz, M. A. (1997a). Attenuation of transient focal cerebral ischemie injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cercb. Blood Flow Mctab. 17, 370-5.
76. Hara, H., Friedlander, R. M., Gagliardini, V., Ayata, C., Fink, K., Huang, Z., ShimizuSasamata, M., Yuan, J., and Moskowitz, M. A. (1997b). Inhibition of interleukin Ibeta converting enzyme family proteases reduces ischémie and excitotoxic neuronal damage. Proc. Nail. Acad. Set. U.S.A. 94, 2007-2012.
77. Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., and Okumura, K. (1998). Differential effects of anti-Fas ligand and antitumor necorosis factor a antibodies on acute graft-versus-host disease pathologies. Blood 91, 4051-4055.
78. Hsu, H., Xiong, J., and Goeddel, D. V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-K B activation Cell 81, 495-504.
79. Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H., and Galle, P. R. (1997). Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells: J. Biol. Chem. 272, 28191-28193.
80. Inohara, N., del Peso, L., Koseki, T., Chen, S., and Nunez, G. (1998). RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273, 12296-12300.
81. Irmler, M., Thome, M., Hahme, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E., and Tschopp, J. (1997). Inhibition of death receptor signals by cellular FLIP. Nature (London) 388, 190-195.
82. Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K., Iwahashi, H., Moriwaki, M., Nakajima, IL, Miyagawa, J., Namba, M., Makino, S., Nagata, S., Kono, N., and Matsuzawa, Y. (1997). Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186, 613-618.
83. Jacobs, C., Backer, P., Roux, E., Picna, K., Toivola, B., Waugh, S., and Kennedy, M. (1991). Experimental autoimmune encaphalomyelitis is exacerbated by IL-1 alpha and suppressed by soluable IL-1 receptor. J. Immunol. 146, 2983-2989.
84. Jacobs, C. A., Beckmann, M. P., Mohler, K., Maliszewski, C. R., Fanslow, W. C., and Lynch, D. H. (1993). Pharmacokinetic parameters and biodistribution of soluble cytokine receptor. Int. Rev. Exp. Pathol. 34, (Pt. B), 123-135.
85. Jaeschke, IL, Fisher, M. A., Lawson, J. A., Simmons, C. A., Farhood, A., and Jones, D. A. (1998). Activation of caspase 3 (CPP32)-Iike proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J. Immunol. 160, 3480-3486.
86. Katsikis, P. D., Wunderlich, E. S., Smith, C. A., and Herzenberg, L. A. (1995). Fas antigen stimulation induces marked apoptosis of T-lymphocytes in human immunodeficiency virus-infected individuals.J. Exp. Med. 181, 2029-2036.
87. Katsikis, P. D., Garcia-Ojeda, M. E., Torres-Roca, J. F., Tijoe, I. M., Smith, C. A., Herzenberg, L. A., and Herzenberg, L. A. (1997). Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activationinduced T cell death in HIV infection. J. Exp. Med. 186, 1365-1372.
88. Kimble, R., Vannice, J., Bloedow, D., Thompson, R., Hopper, W., Kung, V., Brownfield, C., and Pacifici, R. (1994). Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.J. Clin. Invest. 93, 1959-1967.
89. Kiriakidou, M., Driscoll, D. A., Guisa, J. M. L., and Strauss III, J. F. (1997). Cloning and expression of primate Daxx cDNAs and mapping of the human gene to chromosome 6p21.3 in the MHC region. DXA Cell Biol 16, 1289-1298.
90. Kitson, J., Raven, T., Jiang, Y.-P., Goeddel, D. V., Giles, K. M., Pun, K.-T., Grinham, C. J., Broun, R., and Farrow, S. N. (1996). A death-domain containing receptor that mediates apoptosis. Nature (London) 384, 372-375.
91. Ku, G., Faust, T., Lauffer, L. L., Livingston, D. J., and Harding, M. W. (1996). Interleukin-1 beta converting enzyme inhibition blocks progression of typo 11 collagen-induced arthritis in mice. Cytokine 8, 377-386.
92. Kuida, K., Lippke, J., Ku, G., Harding, M., Livingston, D., Su, M., and Flavell, R. (1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme, Science 267, 2000-2002.
93. Lagresle, C., Mondière, P., Bella, C., Krammer, P. IL, and Defrance, T. (1996). Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis.J. Exp. Med. 183, 1377-1388.
94. Lebsack, M., Paul, C., Bloedow, D., Burch, F., Sack, M., Chase, W., and Catalano, M. (1991). Subcutaneous II-l receptor antagonist in patients with rheumatoid arthritis. Arthritis Wieum. 36, S45.
95. Lebsack, M., Paul, C., Martindale, J., and Catalano, M. (1993). A dose and regimen ranging study of IL-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rlieum. 36, S39.
96. Leithauser, F., Dhein, J., and Mechtercheimer, G. (1993). Constitutive and induced expres-sion of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415-429.
97. Lewis, D. E., Ng Tang, D. S., Adu-Oppong, A., Schober, W., and Rodgers, J. R. (1994). Anergy and apoptosis in CD8+ T cells from HlV-infected persons. J. Immtinol. 153, 412-420.
98. Lewthwaite, J., Blake, S., Hardingham, T., Warden, P., and Henderson, B. (1994). The effect of recombinant human interleukin-1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J. Rheumatol. 21.
99. Li, C. J., Friedman, D. J., Wang, C., Metelev, V., and Pardee, A. B. (1995a). Induction of apoptosis in uninfected lymphocytes by IIIV-1 Tat protein. Science 268, 429-431.
100. Li, P., Alien, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E.-Tracey, D., Wardwell, S., Wei, F.-Y., Wong, W., Kamen, R., and Seshadri, T. (1995b). Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80, 401-411.
101. Li, P., Alien, II., Banerjee, S., and Seshadri, T. (1997a). Characterization of mice deficient in interleukin-1 beta converting enzyme. J. Cell. Biochem. 64, 27-32.
102. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S., Ahmad, M., Alnemri, E., and Wang, X. (1997b). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
103. Lin, T., Brunner, T., Tietz, B., Madsen, J., Bonfoco, E., Reaves, M., Hufleit, M., and Green, D. R. (1998). Fas ligand-mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease. J. Clin. Incest. 101, 570-577.
104. Liu, Z.-G., Hsu, IL, Goeddel, D. V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-KB activation prevents cell death. Cell 87, 565-576.
105. MacFarlane, M., Alimad, M., Srinivasula, S., Fernandes-Alnemri, T., Cohen, G., and Alnemri, E. (1997). Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. biol. Chem. 272, 25417-25420.
106. Magram, J., Connaughton, S. E., Warner, R. R., Carvajal, D. M., Wu, G. Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A. and Gately, M. K. (1996). IL-12-deficient mice are defective in IFN gamma production and type-1 cytokine responses. Immunity 4, 471-481.
107. Mariani, S. M., and Krammer, P. H. (199S). Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Enr. ]. Immtmol. 28, 1492-1498.
108. Mariani, S. M., Matiba, B., Armandola, E. A., and Krammer, P. II. (1997). Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell Biol. 137, 221-229.
109. Marsters, S., Sheridan, J., Pitti, R., Brush, J., Goddard, A., and Ashkenazi, A. (1998). Identification of a ligand for the death-domain-containing receptor Apo3. Ciirr. Biol. 8, 525-528.
110. Martin, R., McFarland, H., and McFarlin, D. (1992). Immunological aspects of demyelinating diseases. Annn. Rev. Immtinol. 10, 153-187.
111. McAlindon, M. E., Hawkey, C. J., and Manida, Y. R. (1998). Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 42, 214-219.
112. McCarthy, P., Abhyankar, S., and Neben, S. (1991). Inhibition of interleukin-1 by interleukin-1 receptor antagonist presents graft vs. host disease. Blood 78, 1915-1918.
113. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevdhenko, A., Mann, M., Krammer, P. II., and Peter, M. E. (1997). FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804. Medema, J., Scaffidi, C., Krammer, P., and Peter, M. (1998). Bel-XL acts downstream of FLICE/caspase-8. J. Biol. Chem. 273, 3388-3393.
114. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukada, S., and Kurimoto, M. (1996). Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26, 1647-1651.
115. Miura, M., Zhu, II., Rotello, R., Hartwieg, E. A., and Yuan, J. (1993). Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 Cell 75, 653-660.
116. Muschen, M., Warskulat, U., Douillard, P., Gilbert, E., and Haussinger, D. (1998). Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopoolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 27, 200-208.
117. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O' Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. IL, Peter, M. E., and Dixit, V. M. (1996). Flice, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
118. Neurath, M. F., Fuss, L, Kelsall, B. L., Stuber, E., and Strober, W. (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice.J. Exp. Med. 182, 1281-1290.
119. Nishigaki, K., Minatoguchi, S., Seishima, M., Asano, K., Noda, T., Yasuda, N., Sano, H., Kumada, IL, Takemura, M., Noma, A., Tanaka, T., Watanabe, S., and Fujiwara, H. (1997). Plasma Fas ligand, an inducer of apoptosis, and plasma soluable Fas, an inhibitor of apoptosis; in patients with chronic congestive heart failure.J. Am. Coll. Cardiol. 29, 1214-1220.
120. Nishina, H., Fischer, K. D., Radvanyl, L., Shahinian, A., Hakem, R., Rubie, E. A., Bernstein, A., Mak, T. W., Woodgett, J. R., and Penninger, J. M. (1997). Stress-signalling kinase Sekl protects thymocytes from apoptosis mediated by CD95 and CD3. Nature (London) 385, 350-353.
121. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, NL, Suda, T., and Nagata, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature (London) 364, 806-809.
122. Ohlsson, K., Bjork, P., Bergenfeldt, M., Hageman, R., and Thompson, R. (1990). Interleukin1 receptor antagonist reduces mortality from endotoxin shock. Nature (London) 348, 550-552.
123. Okamura, IL, Tsutsi, IL, Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada Hattori, K., et al. (1995). Cloning of a new cytokine that induces IFNgamma production by T cells. Nature (London) 378, 88-91.
124. Opal, S. M., Fisher, C. J., Jr., Dhainaut, J. F., Vincent, J. L., Erase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, IL, Balk, R. A., Shelly, M. P., Fribble, J. P., LaBrecque, J. F., Lookabaugh, J., Donovan, IL, Dubin, IL, Baughman, R., Norman, J., DeMaria, E., Matzel, K., Abraham, E., and Seneff, M. (1997). Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit. Care Meet 25, 1115-1124.
125. Orth, K., O'Rourke, K., Salvesen, G. S., and Dixit, V. M. (1996). Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J. Biol. Cliem. 271, 20977-20980.
126. Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R., and Dixit, V. M. (1997a). An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818.
127. Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., and Dixit, V. M. (1997b). The receptor of the cytotoxic ligand TRAIL. Science 276, 111-113.
128. Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K. M., and Krammer, P. II. (1997). Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACII/caspase 8) to the CD95 death-inducing signaling complex. Eur. ]. Immiinol. 27, 1207-1212.
129. Rano, T. A., Timkey, T., Peterson, E. P., Rotonda, J., Nicholson, D. W., Becker, J. W., Chapman, K. T., and Thomberry, N. A. (1997). A combinatorial approach for determining protease specificities: Application to interleukin-lbeta converting enzyme (ICE). Cliem. Biol. 4, 149-155.
130. Relton, J., and Rothvvell, N. (1992). Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29, 243-246.
131. Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Gui, IL, Ju, S.-T., and Marshak-Rothstein, A. (1995). Protection against fas-dependent Thlmediated apoptosis by antigen receptor engagement in B cells. Nature (London) 374, 163-165.
132. Rotonda, J., Nicholson, D. W., Fazil, K. M., Gallant, M., Gareau, Y., Labelle, M., Peterson, E. P., Rasper, D. M., Ruel, R., Vaillancourt, J. P., Thornberry, N. A., and Becker, J. W. (1996). The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Struct. Biol. 3, 619-625.
133. Sabelko, K., Kelly, K., Nahm, M., Cross, A., and Russell, J. (1997). Fas and Fas ligand enhance the pathogenesis of experimental allergi encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159, 3096-3099.
134. Sakai, T., Kimura, Y., Inagaki-Ohara, K., Kusugami, K., Lynch, D. IL, and Yoshikai, Y. (1997). Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice. Gastroenterology 113, 168-174.
135. Salvesen, G. S., and Dixit, V. M. (1997). Caspases: Intracellular signaling by proteolysis. Cell 91, 443-446.
136. Sato, T., Irie, S., Kitada, S., and Reed, J. C. (1995). FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268, 411-415.
137. Schattner, E. J., Elkon, K. B., Yoo, D., Tumang, J., Krammer, P. IL, Crow, M. K., and Friedman, S. M. (1995). CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Mcd. 182, 1557-1565.
138. Schönbeck, U., Mach, F., Bonnefoy, J.-Y., Loppnow, H., Flad, H.-D., and Libby, P. (1997). Ligation of CD40 activates interleukin 1β-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 10. J. Biol. Chem. 272, 19569-19574.
139. Schumann, R. R., Belka, C., Reuter, D., Lamping, N., Kirschning, C. J., Weber, J. R., and Pfeil, D. (1998). Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 91, 577-584.
140. Schwab, J., Anderle, S., Brown, R., Dalldorf, F., and Thompson, R. (1991). Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect. Immunol. 59, 4436-4442.
141. Seino, K., Kayagaki, N., Bashuda, IL, Okumura, K., and Yagita, H. (1996). Contribution of Fas ligand to cardiac allograft rejection. Int. Immunol. 8, 1347-1354.
142. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gumey, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P., and Ashkenazi, A. (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors [see comments]. Science 277, 818-21.
143. Shi, L., Chen, G., MacDonald, G., Bergeron, L., Li, IL, Miura, M., Rotello, R. J., Miller, D. K., Li, P., Seshadri, T., Yuan, J., and Greenberg, A. (1996). Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc. Natl. Acad. Sci. U.S.A. 93, 11002-11007.
144. Sillence, D. J., and Allan, D. (1997). Evidence against an early signalling role for ceramide in Fas-mediated apoptosis. Biochem. J. 324, 29-32.
145. Smith, K. G. C., Strasser, A., and Vaux, D. L. (1996). CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (FAS/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176.
146. Smyth, M. J., Obeid, L. M., and Hannun, Y. A. (1997). Ceramide: A novel lipid mediator of apoptosis. In "Apoptosis: Pharmacological Implications and Therapeutic Opportunities" (S. II. Kaufmann, ed.), pp. 133-154. Academic Press, San Diego.
147. Sneller, M. C., Wang, J., Dale, J. K., Strober, W., Middleton, L. A., Choi, Y., Fleisher, T. A., Lim, M. S., Jaffe, E. S., Puck, J. M., Lenardo, M. J., and Straus, S. E.' (1997). Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89, 1341-1348.
148. L functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J. Biol. Chem. 273, 4523-4529.
149. Srinivasula, S., Ahmad, M., Femandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1996). Molecular ordering of the fas-apoptotic pathway: The fas/APO-1 protease Mch5 is a
150. CrmA-inhibitableprotease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. U.S.A. 93, 14486-14491.
151. Srinivasula, S. M., Ahmad, M., Ottilie, S., Bullrich, F., Banks, S., Wang, Y., Femandes-Alnemri, T., Croce, C. M., Litwack, G., Tomaselli, K. J., Armstrong, R. C., and Alnemri, E. S. (1997). FLAME-1, a novel FADD-Iike antiapoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. B/oJ. Chem. 272, 18542-18545.
152. Stassi, G., Maria, R., Trucco, G., Rudert, W., Testi, R., Galluzzo, A., Giordano, C., and Trucco, M. (1997). Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186, 1193-2000.
153. Steinman, L. (1996). Multiple sclerosis: A coordinated immunological attack against myolin in the central nervous system. Cell, 85, 299-302.
154. Stennicke, H. R., and Salvesen, G. S. (1997). Biochemical characteristics of caspase-3, -6, -7, and -8. J. Biol Chem. 272, 25719-25723.
155. Strand, S., Hofmann, W. J., Grambihler, A., Hug, H., Volkmann, M., Otto, G., Wesch, H.,
156. Mariani, S. M., Hack, V., Stremmel, W., Krammer, P. H., and Galle, P. R. (1998). Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas)-mediated apoptosis. Nature Med. 4, 588-593.
157. Strater, J., Wellisch, L, Riedl, S., Walczak, H., Koretz, K., Tandara, A., Krammer, P. H., and Moller, P. (1997). CD95 (APO-l/Fas)-mediated apoptosis in colon-epithelial cells: A possible role in ulcerative colitis. Gastroenterology 113, 160-167.
158. Stricker, K., Knipping, E., Bohler, T., Benner, A., Krammer, P., and Debatin, K. (1998). Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children. Cell Death Differ. 5, 222-230.
159. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
160. Talley, A. K., Dewhurst, S., Perry, S. W., Dollard, S. C., Gummuluru, S., Fine, S. M., New, D., Epstein, L. G., Gendelman, H. E., and Gelbard, H. A. (1995). Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15, 2359-2366.
161. Tartaglia, L. A., and Goeddel, D. V. (1992). Two TNF receptors. Immunol Today 13, 151-153.
162. Tewari, M., Beidler, D. R., and Dixit, V. M. (1995a). CrmA-inhibitable cleavage of the 70-kDa protein component of the Ul small nuclear ribonucleoprotein during Fas- and tumor necrosis factor-induced apoptosis. J. Biol Chem. 270, 18738-18741.
163. Tewari, M., Telford, W. G., Miller, R. A., and Dixit, V. M. (1995b). CrmA, apoxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem. 270, 1-4.
164. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Bums, K., Bodmer, J.-L., Schroter, M., Scaffidi, C., Krammer, P. H., Peter, M. E., and Tschopp, J. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (London) 386, 517-521.
165. Thompson, R., Dripps, D., and Eisenberg, S. (1992). Interleukin-1 receptor anatagonist as a probe and as a treatment for IL-1 mediated disease. Int. J. Immunopharmacol. 14, 475-480.
166. Thomberry, N., Rano, T., Peterson, E., Rasper, D., Timkey, T., Garcia-Calvo, M., Houtzager, V., Nordstrom, P., Roy, S., Vaillancourt, J., Chapman, K., and Nicholson, D. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272, 17907-17911.
167. Tisch, R., and McDevitt, H. (1996). Insulin-dependent diabetes mellitus. Cell 85, 291-297.
168. Torigoe, T., Millan, J. A., Takayama, S., Taichman, R., Miyashita, T., and Reed, J. C. (1994). Bcl-2 inhibits T-cell-mediated cytolysis of leukemia cell line. Cancer Res. 54,4851-4854.
169. Toyoshima, F., Moriguchi, T., and Nishida, E. (1997). Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J. Cell. Biol. 139, 1005-1015.
170. Toyozaki, T., Hiroe, M., Saito,T., Ijima, Y., Takano, H., Hiroshima, K., Kohno, H., Ishiyama, S., Marumo, F., Masuda, Y., and Ohwada, H. (1998). Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin and in healthy volunteers. Am. J. Cardiol. 81, 798-800.
171. Umansky, S. R., and Tomei, L. D. (1997). Apoptosis in the heart. In "Apoptosis: Pharmacological Implications and Therapeutic Opportunities" (S. H. Kaufmann, ed.), pp. 383-407. Academic Press San Diego.
172. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., et al., (1996). Cloning of the cDNA for human IFN-gamma inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156, 4274-4279.
173. Van Den Berg, W., Joosten, L., Helsen, M., and Van De Loo, F. (1994). Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95, 237-243.
174. Van Parjis, L., and Abbas, A. K. (1996). Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8, 355-361.
175. Van Parjis, L., and Abbas, A. (1998). Homeostasis and self tolerance in the immune system: Turning lymphocytes off. Science 280, 243-248.
176. Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., Lapidot, T., Soffer, D., Sobe, T., Avraham, K. B., Goncharov, T., Holtmann, H., Lonai, P., and Wallach, D. (1998). Targeted disruption of the mouse capsase 8 gene ablates cell death inducation by the TNF receptors, Fas/Apo 1, and DR3 and is lethal prenatlally Immunity 9, 267-276.
177. Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., and Vandenabeele, P. (1998). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tuinor necrosis factor. J. Exp. Med. 187, 1477-1485.
178. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (London) 380, 75-79.
179. Via, C. S., Nguyen, P., Shustov, A., Drappa, J., and Elkon, K. B. (1996). A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 157, 5387-5393.
180. Vincenz, C., and Dixit, V. M (1997). Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediate death-signaling. J. Biol. Chem. 272, 6578-6583.
181. Wakabayashi, G., Gelfand, J., Burke, J., Thompson, R., and Dinarello, C. (1997). A specific receptor antagonist for interleukin-2 prevents Escherichia coli-induced shock. FASEB J. 5, 338-343.
182. Waldner, IL, Sobel, R., Howard, E., and Kuchroo, V. (1997). Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis.J. Immunol. 159, 3100-3103.
183. Wallach, D., Boldin, M., Varfolomeev, E., Beyaert, R., Vandenabeele, P., and Fiers, W. (1997). Cell death induction by receptors of he TNF family: Towards a molecular understanding. FEBS Lett. 410, 96-106.
184. Wang, C.-Y., Mayo, M. W., and Baldwin, A. S. (1996a). TNF- and cancer therapy-induced apoptosis: Potentation by inhibition of NF-KB. Science 274, 784-787.
185. Wang, S., Miura, M., Zhu, H., Gagliardini, V., and Yuan, J. (1996b). Idenification and characterization of caspase-11, a member of the ICE/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 271, 20580-20587.
186. Wang, S., Miura, M., Jung, Y. K., Zhu, H., Li, E., and Yuan, J. (1998). Murine caspase-II, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501-509.
187. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 356, 314-317.
188. Westendorp, M. O., Frank, R., Ochsenbauer, G., Stricker, K., Dhein, J., Waleczak, H., Debatin, K.-M., and Krammer, P. H. (1995). Sensitization of T cells to CD 95 mediated apoptosis by HIV-1 Tat and gp120. Nature (London) 375, 497-500.
189. Wilson, K. P., Black, J. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Mureko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., and Livingston, D. J. (1994). Structure and mechanism and interleukin-1βconverting enzyme. Nature (London) 370, 270-275.
190. Wooley, P., Whalen, J., Chapman, D., Berger, A., Richard, K., Aspar, D., and Staite, N. (1993). The effect of an interleukin-1 receptor antagonist proteins on type II collagen-induced arthritis and antigen-induced in mice. Arthritis Rheum. 36, 1305-1314.
191. Yang, X., Khosravi-Far, R., Chang, H. Y., and Baltimore, D. (1997). Daxx a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076.
192. Yao, J., and Johnson, R. W. (1997). Induction of interleukin-1 beta-converting enzyme (ICE) in murine microglia by lipopolysaccharide. Mol. Brain Res. 51, 170-178.
193. Yaoita, H., Ogawa, K., Maehara, K., and Maruyaina, Y. (1997). "Attenuation of Ischemia/Reperfusion Injury in Rats by a caspase Inhibitor." Basic Science Reports, pp. 276-281.
194. Yeh, W., De La Pompa, J., El-Deiry, W., Lowe, S., Goeddel, D., and Mak, T. (1998). FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958.
195. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. (1993). The C. elegans cell death gene ccd-3 encodes a protein similar to mammalian interleukin-1 beta converting enzyme. Cell 75, 641-652.
196. Zhang, J., Cado, C., Chen, A., Kabra, N., and Winota, A. (1998a). Fas-mediated apoptosis and activation-induced T cell proliferation are defective in mice lacing FADD/Mort Nature (London) 392, 296-299.
197. Zhang, Y., Center, D. M., Wu, M. H., Cruikshank, W. W., Yuan, J., Andrews, D. W., and Kornfeld, H. (1998b). Processsing and-activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 273, 1144-1149.
198. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M., and Salvesen, G. S. (1997). Target protease specificity of the viral serpin CrmA: Analysis of five caspases. J. Biol. Chem. 272, 7797-7800.